AstraZeneca PLC ADR (AZN)
$66.58 -$0.38 (-0.57%) 5:50 AM 12/15/24
NASDAQ | $USD | Drug Manufacturers - GeneralStock Data
-
Market Cap
$209.14B -
Day's Range
$66.14 - $66.69 -
Volume
5,213,108 -
52 Week Low / High
$59.19 - $87.68 -
PE Ratio
32.01x -
PEG Ratio
0.72 -
Dividend Frequency
irregular
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 6
- Strong Buy
- 4
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $83.71
- Target Price
Company News
-
UK Stocks That May Be Trading Below Estimated Value — Oct 21st, 2024
The United Kingdom's stock market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines amid weak trade data from China, highlighting global economic uncertainties. In such a climate, identifying stocks that may be trading below their estimated value c...
-
AstraZeneca Reverses As Beat And Raise Outweighs Drug Smuggling Claims — Nov 12th, 2024
AstraZeneca beat third-quarter expectations and lifted its guidance Tuesday, and AstraZeneca stock rose despite a criminal probe in China. Continue reading View comments...
-
China Has Detained a Senior AstraZeneca Executive — Nov 7th, 2024
Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese government is probing AstraZeneca employees. Continue reading View comments...
-
UK Stocks That May Be Trading Below Estimated Value — Oct 21st, 2024
The United Kingdom's stock market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines amid weak trade data from China, highlighting global economic uncertainties. In such a climate, identifying stocks that may be trading below their estimated value c...
-
Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat — Nov 4th, 2024
Viking Therapeutics' highly anticipated weight-loss pill topped Wall Street's expectations — and a rival pill from Novo Nordisk — after just four weeks of treatment. Patients who took the highest dose of Viking's pill lost 8.2% of their body weight. The 6.8% difference is far better th...
-
UK Stocks That May Be Trading Below Estimated Value — Oct 21st, 2024
The United Kingdom's stock market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines amid weak trade data from China, highlighting global economic uncertainties. In such a climate, identifying stocks that may be trading below their estimated value c...
-
UK Stocks That May Be Trading Below Estimated Value — Oct 21st, 2024
The United Kingdom's stock market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines amid weak trade data from China, highlighting global economic uncertainties. In such a climate, identifying stocks that may be trading below their estimated value c...
-
China Has Detained a Senior AstraZeneca Executive — Nov 7th, 2024
Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese government is probing AstraZeneca employees. Continue reading View comments...
-
UK Stocks That May Be Trading Below Estimated Value — Oct 21st, 2024
The United Kingdom's stock market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines amid weak trade data from China, highlighting global economic uncertainties. In such a climate, identifying stocks that may be trading below their estimated value c...
-
Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat — Nov 4th, 2024
Viking Therapeutics' highly anticipated weight-loss pill topped Wall Street's expectations — and a rival pill from Novo Nordisk — after just four weeks of treatment. Patients who took the highest dose of Viking's pill lost 8.2% of their body weight. The 6.8% difference is far better th...
-
China Has Detained a Senior AstraZeneca Executive — Nov 7th, 2024
Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese government is probing AstraZeneca employees. Continue reading View comments...
-
AstraZeneca Reverses As Beat And Raise Outweighs Drug Smuggling Claims — Nov 12th, 2024
AstraZeneca beat third-quarter expectations and lifted its guidance Tuesday, and AstraZeneca stock rose despite a criminal probe in China. Continue reading View comments...
-
UK Stocks That May Be Trading Below Estimated Value — Oct 21st, 2024
The United Kingdom's stock market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines amid weak trade data from China, highlighting global economic uncertainties. In such a climate, identifying stocks that may be trading below their estimated value c...
-
AstraZeneca Reverses As Beat And Raise Outweighs Drug Smuggling Claims — Nov 12th, 2024
AstraZeneca beat third-quarter expectations and lifted its guidance Tuesday, and AstraZeneca stock rose despite a criminal probe in China. Continue reading View comments...
-
Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat — Nov 4th, 2024
Viking Therapeutics' highly anticipated weight-loss pill topped Wall Street's expectations — and a rival pill from Novo Nordisk — after just four weeks of treatment. Patients who took the highest dose of Viking's pill lost 8.2% of their body weight. The 6.8% difference is far better th...
-
China Has Detained a Senior AstraZeneca Executive — Nov 7th, 2024
Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese government is probing AstraZeneca employees. Continue reading View comments...
-
Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat — Nov 4th, 2024
Viking Therapeutics' highly anticipated weight-loss pill topped Wall Street's expectations — and a rival pill from Novo Nordisk — after just four weeks of treatment. Patients who took the highest dose of Viking's pill lost 8.2% of their body weight. The 6.8% difference is far better th...
-
Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat — Nov 4th, 2024
Viking Therapeutics' highly anticipated weight-loss pill topped Wall Street's expectations — and a rival pill from Novo Nordisk — after just four weeks of treatment. Patients who took the highest dose of Viking's pill lost 8.2% of their body weight. The 6.8% difference is far better th...
-
Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat — Nov 4th, 2024
Viking Therapeutics' highly anticipated weight-loss pill topped Wall Street's expectations — and a rival pill from Novo Nordisk — after just four weeks of treatment. Patients who took the highest dose of Viking's pill lost 8.2% of their body weight. The 6.8% difference is far better th...
-
China Has Detained a Senior AstraZeneca Executive — Nov 7th, 2024
Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese government is probing AstraZeneca employees. Continue reading View comments...
-
AstraZeneca Reverses As Beat And Raise Outweighs Drug Smuggling Claims — Nov 12th, 2024
AstraZeneca beat third-quarter expectations and lifted its guidance Tuesday, and AstraZeneca stock rose despite a criminal probe in China. Continue reading View comments...
-
Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat — Nov 4th, 2024
Viking Therapeutics' highly anticipated weight-loss pill topped Wall Street's expectations — and a rival pill from Novo Nordisk — after just four weeks of treatment. Patients who took the highest dose of Viking's pill lost 8.2% of their body weight. The 6.8% difference is far better th...
-
AstraZeneca Reverses As Beat And Raise Outweighs Drug Smuggling Claims — Nov 12th, 2024
AstraZeneca beat third-quarter expectations and lifted its guidance Tuesday, and AstraZeneca stock rose despite a criminal probe in China. Continue reading View comments...
-
China Has Detained a Senior AstraZeneca Executive — Nov 7th, 2024
Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese government is probing AstraZeneca employees. Continue reading View comments...
-
AstraZeneca Reverses As Beat And Raise Outweighs Drug Smuggling Claims — Nov 12th, 2024
AstraZeneca beat third-quarter expectations and lifted its guidance Tuesday, and AstraZeneca stock rose despite a criminal probe in China. Continue reading View comments...
-
China Has Detained a Senior AstraZeneca Executive — Nov 7th, 2024
Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese government is probing AstraZeneca employees. Continue reading View comments...
-
China Has Detained a Senior AstraZeneca Executive — Nov 7th, 2024
Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese government is probing AstraZeneca employees. Continue reading View comments...
-
China Has Detained a Senior AstraZeneca Executive — Nov 7th, 2024
Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese government is probing AstraZeneca employees. Continue reading View comments...
-
AstraZeneca Reverses As Beat And Raise Outweighs Drug Smuggling Claims — Nov 12th, 2024
AstraZeneca beat third-quarter expectations and lifted its guidance Tuesday, and AstraZeneca stock rose despite a criminal probe in China. Continue reading View comments...
-
AstraZeneca Reverses As Beat And Raise Outweighs Drug Smuggling Claims — Nov 12th, 2024
AstraZeneca beat third-quarter expectations and lifted its guidance Tuesday, and AstraZeneca stock rose despite a criminal probe in China. Continue reading View comments...
-
AstraZeneca Reverses As Beat And Raise Outweighs Drug Smuggling Claims — Nov 12th, 2024
AstraZeneca beat third-quarter expectations and lifted its guidance Tuesday, and AstraZeneca stock rose despite a criminal probe in China. Continue reading View comments...
-
AstraZeneca Reverses As Beat And Raise Outweighs Drug Smuggling Claims — Nov 12th, 2024
AstraZeneca beat third-quarter expectations and lifted its guidance Tuesday, and AstraZeneca stock rose despite a criminal probe in China. Continue reading View comments...
-
AstraZeneca Reverses As Beat And Raise Outweighs Drug Smuggling Claims — Nov 12th, 2024
AstraZeneca beat third-quarter expectations and lifted its guidance Tuesday, and AstraZeneca stock rose despite a criminal probe in China. Continue reading View comments...
-
AstraZeneca Reverses As Beat And Raise Outweighs Drug Smuggling Claims — Nov 12th, 2024
AstraZeneca beat third-quarter expectations and lifted its guidance Tuesday, and AstraZeneca stock rose despite a criminal probe in China. Continue reading View comments...
-
Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat — Nov 4th, 2024
Viking Therapeutics' highly anticipated weight-loss pill topped Wall Street's expectations — and a rival pill from Novo Nordisk — after just four weeks of treatment. Patients who took the highest dose of Viking's pill lost 8.2% of their body weight. The 6.8% difference is far better th...
-
Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat — Nov 4th, 2024
Viking Therapeutics' highly anticipated weight-loss pill topped Wall Street's expectations — and a rival pill from Novo Nordisk — after just four weeks of treatment. Patients who took the highest dose of Viking's pill lost 8.2% of their body weight. The 6.8% difference is far better th...
-
China Has Detained a Senior AstraZeneca Executive — Nov 7th, 2024
Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese government is probing AstraZeneca employees. Continue reading View comments...
-
Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat — Nov 4th, 2024
Viking Therapeutics' highly anticipated weight-loss pill topped Wall Street's expectations — and a rival pill from Novo Nordisk — after just four weeks of treatment. Patients who took the highest dose of Viking's pill lost 8.2% of their body weight. The 6.8% difference is far better th...
-
China Has Detained a Senior AstraZeneca Executive — Nov 7th, 2024
Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese government is probing AstraZeneca employees. Continue reading View comments...
-
Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat — Nov 4th, 2024
Viking Therapeutics' highly anticipated weight-loss pill topped Wall Street's expectations — and a rival pill from Novo Nordisk — after just four weeks of treatment. Patients who took the highest dose of Viking's pill lost 8.2% of their body weight. The 6.8% difference is far better th...
-
Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat — Nov 4th, 2024
Viking Therapeutics' highly anticipated weight-loss pill topped Wall Street's expectations — and a rival pill from Novo Nordisk — after just four weeks of treatment. Patients who took the highest dose of Viking's pill lost 8.2% of their body weight. The 6.8% difference is far better th...
-
Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat — Nov 4th, 2024
Viking Therapeutics' highly anticipated weight-loss pill topped Wall Street's expectations — and a rival pill from Novo Nordisk — after just four weeks of treatment. Patients who took the highest dose of Viking's pill lost 8.2% of their body weight. The 6.8% difference is far better th...
-
Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat — Nov 4th, 2024
Viking Therapeutics' highly anticipated weight-loss pill topped Wall Street's expectations — and a rival pill from Novo Nordisk — after just four weeks of treatment. Patients who took the highest dose of Viking's pill lost 8.2% of their body weight. The 6.8% difference is far better th...
-
China Has Detained a Senior AstraZeneca Executive — Nov 7th, 2024
Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese government is probing AstraZeneca employees. Continue reading View comments...
-
UK Stocks That May Be Trading Below Estimated Value — Oct 21st, 2024
The United Kingdom's stock market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines amid weak trade data from China, highlighting global economic uncertainties. In such a climate, identifying stocks that may be trading below their estimated value c...
-
China Has Detained a Senior AstraZeneca Executive — Nov 7th, 2024
Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese government is probing AstraZeneca employees. Continue reading View comments...
-
China Has Detained a Senior AstraZeneca Executive — Nov 7th, 2024
Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese government is probing AstraZeneca employees. Continue reading View comments...
-
AstraZeneca Reverses As Beat And Raise Outweighs Drug Smuggling Claims — Nov 12th, 2024
AstraZeneca beat third-quarter expectations and lifted its guidance Tuesday, and AstraZeneca stock rose despite a criminal probe in China. Continue reading View comments...
-
AstraZeneca Reverses As Beat And Raise Outweighs Drug Smuggling Claims — Nov 12th, 2024
AstraZeneca beat third-quarter expectations and lifted its guidance Tuesday, and AstraZeneca stock rose despite a criminal probe in China. Continue reading View comments...
-
UK Stocks That May Be Trading Below Estimated Value — Oct 21st, 2024
The United Kingdom's stock market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines amid weak trade data from China, highlighting global economic uncertainties. In such a climate, identifying stocks that may be trading below their estimated value c...
Portfolio
Comprised of 1 portfolios